Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Polis

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Revue Medicale De Liege|August 2, 2008
[Depression and neuroplasticity]W Pitchot, M Polis, S Belachew, et al.
Annals of Internal Medicine|July 15, 1996
Advances in the management of AIDS-related cytomegalovirus retinitisH Masur, S M Whitcup, C Cartwright, et al.
AIDS Research and Human Retroviruses|August 1, 1992
Phase I/II studies of the toxicity and immunogenicity of recombinant gp160 and p24 vaccines in HIV-infected individualsK M Zunich, H C Lane, R T Davey, et al.
Journal of Viral Hepatitis|January 14, 2012
CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signallingA Katsounas, M Trippler, B Wang, et al.
AIDS (London, England)|January 1, 1994
The use of the flarephotometry in the detection of cytomegalic virus retinitis in AIDS patientsR B Nussenblatt, M De Smet, M Podgor, et al.
AIDS (London, England)|September 1, 1996
Relationship between foscarnet exposure, baseline cytomegalovirus (CMV) blood culture and the time to progression of CMV retinitis in HIV-positive patientsG L Drusano, F Aweeka, J Gambertoglio, et al.
The New England Journal of Medicine|December 8, 1991
A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndromeJ Falloon, J Kovacs, W Hughes, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumoniaJ Falloon, J Lavelle, D Ogata-Arakaki, et al.
AIDS Research and Human Retroviruses|December 16, 2000
Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patientsJ C Gea-Banacloche, L Martino, J M Mican, et al.
Annals of Internal Medicine|October 1, 1985
Cryptococcosis in the acquired immunodeficiency syndromeJ A Kovacs, A A Kovacs, M Polis, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Revue Medicale De Liege|August 2, 2008
[Depression and neuroplasticity]W Pitchot, M Polis, S Belachew, et al.
Annals of Internal Medicine|July 15, 1996
Advances in the management of AIDS-related cytomegalovirus retinitisH Masur, S M Whitcup, C Cartwright, et al.
AIDS Research and Human Retroviruses|August 1, 1992
Phase I/II studies of the toxicity and immunogenicity of recombinant gp160 and p24 vaccines in HIV-infected individualsK M Zunich, H C Lane, R T Davey, et al.
Journal of Viral Hepatitis|January 14, 2012
CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signallingA Katsounas, M Trippler, B Wang, et al.
AIDS (London, England)|January 1, 1994
The use of the flarephotometry in the detection of cytomegalic virus retinitis in AIDS patientsR B Nussenblatt, M De Smet, M Podgor, et al.
AIDS (London, England)|September 1, 1996
Relationship between foscarnet exposure, baseline cytomegalovirus (CMV) blood culture and the time to progression of CMV retinitis in HIV-positive patientsG L Drusano, F Aweeka, J Gambertoglio, et al.
The New England Journal of Medicine|December 8, 1991
A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndromeJ Falloon, J Kovacs, W Hughes, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumoniaJ Falloon, J Lavelle, D Ogata-Arakaki, et al.
AIDS Research and Human Retroviruses|December 16, 2000
Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patientsJ C Gea-Banacloche, L Martino, J M Mican, et al.
Annals of Internal Medicine|October 1, 1985
Cryptococcosis in the acquired immunodeficiency syndromeJ A Kovacs, A A Kovacs, M Polis, et al.
Pageof 2